SCHEMBL29292635

SCHEMBL29292635

CCOc1cc(C)c(CN)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.41
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36
▸ TUBA1A Q71U36 1/20 0.36
▸ TUBA1C Q9BQE3 1/20 0.36
▸ TUBB6 Q9BUF5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13828731 0.85 CYP1A2 (0.44) KDM4EGAAALDH1A1TAAR1CD274
SCHEMBL29292637 0.80 CD274 (0.40) HTR2AKDM4EGAAMAPTTUBB4A
SCHEMBL17689591 0.77 NQO1 (0.42) HTR2AHTR2CHTR2BKDM4EGAA
SCHEMBL15434469 0.75 NQO1 (0.44) HTR2AHTR2CHTR2BKDM4EGAA
SCHEMBL18071781 0.73 NQO1 (0.46) KDM4EMAPTALDH1A1NQO1
SCHEMBL442070 0.73 CYP1A2 (0.50) ALDH1A1TAAR1
SCHEMBL13067435 0.72 ALDH1A1 (0.40) KDM4EGAAALDH1A1
SCHEMBL17955664 0.71 CD274 (0.46) KDM4EGAAMAPTTUBB4ATUBB
SCHEMBL8384913 0.71 NQO1 (0.37) AOC3KDM4EMAPTALDH1A1NQO1
SCHEMBL2759497 0.71 TUBB4A (0.61) HTR2AHTR2CHTR2BKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228544-A1 HEMAGGLUTININ-BINDING PEPTIDE PEPTIDREAM INC. (JP) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228544-A1 HEMAGGLUTININ-BINDING PEPTIDE HGFAC, HM13, HIRA AOC3 4868/4885HTR2A 928/4885HTR2C 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback